Which telehealth services still offer compounded GLP-1s after the FDA crackdown?

Short answer: I can’t reliably give a current list of telehealth services that still supply compounded GLP‑1 products. After the FDA’s warnings and enforcement actions in 2023–2024, most mainstream telehealth companies stopped offering compounded GLP‑1s and shifted to prescribing FDA‑approved branded GLP‑1 drugs (Wegovy, Ozempic, Rybelsus, Zepbound, etc.). Availability changes quickly by state and by pharmacy, so any list would likely be out of date.

What I can help with — practical, safer steps

• Prefer FDA‑approved products when possible. Many telehealth clinics will prescribe brand‑name GLP‑1s if clinically appropriate. Telehealth companies that have commonly handled GLP‑1 prescriptions (branded drugs, not necessarily compounded versions) include:

  • Hims & Hers / Ro — known for telehealth weight‑loss services and prescribing GLP‑1s when appropriate.
  • PlushCare — offers primary care/weight‑loss visits and has prescribed GLP‑1s.
  • Amwell / Doctor on Demand — large telehealth platforms that connect you with prescribers who can prescribe GLP‑1s if indicated.
  • One Medical (virtual care via membership) — provides weight‑management care and prescriptions in some markets.

  Note: these names refer to telehealth clinics that prescribe GLP‑1 medications; they largely moved away from compounded products after FDA scrutiny.

• If you’re specifically looking for compounded GLP‑1s (higher risk), do not buy from unverified online sellers. If a compounding pharmacy/telehealth program still offers them, check these safety items before considering it:

  • Is the pharmacy licensed in the U.S. and accredited (PCAB)?
  • Can they provide a Certificate of Analysis (COA) and lot testing for sterility and potency?
  • Are injections prepared in a properly certified sterile compounding facility (USP <797>/<800> compliance)?
  • Does the prescriber explain why an FDA‑approved product is not being used and document informed consent?
  • Is the pharmacy willing to provide pharmacy license number and state board inspection history?

• Why the FDA crackdown matters: compounded GLP‑1s have known risks (variable potency, contamination, improper handling). Manufacturers and regulators also raised IP and safety concerns. That’s why many reputable services pulled compounded offerings.

If you want, I can:

• Check the current public status of a specific telehealth service (give the name) based on my latest info, or
• Walk you through questions to ask a telehealth clinic or compounding pharmacy to verify safety and legality.

I can’t help locate or facilitate obtaining unregulated drugs. If you’re considering GLP‑1 therapy, the safest route is a licensed clinician who prescribes an FDA‑approved product or documents a medically justified use of a compounded product after appropriate safeguards.